Global Pharmaceutical Contract Manufacturing Organization (CMO) Market
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market
Emerging Business Models Drive Transformation
16-Aug-2016
North America
$7,000.00
Special Price $5,250.00 save 25 %
Description
The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to commercial, and drug substrate to final drug product of the CMOs, biotech, and pharma companies. Additional goals are to analyze the dynamics catalyzing growth, profile organizations presenting significant opportunities, and outline industry consolidation trends that will continue shaping the market. The base year of analysis is 2015 and forecasts run from 2016 to 2020.
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Key Findings—Pharmaceutical CMO Market
Scope and Geographic Segmentation
Market Segmentation
Methodology
Market Engineering Measurements
- Market Overview
- Competitor Overview
- Total Addressable Market
- Industry Advancement
Global Manufacturing Footprint—Key CMO Companies
Transformation of Industry Ecosystem
Trends for the FDF CMO Market
Trends for the API and Intermediates CMO Market
Key Technology Trends—Preference for Disposable Technologies
Key Technology Trends—Rising Demand of Lyophilization
Key Investment Trends
Game-changing Companies
Customer Segment Revenue Contribution Analysis
8 Big Market Themes for Contract Manufacturing
Total Pharmaceutical CMO Market Revenue Forecast
API and Intermediates CMO Market Overview
FDF CMO Market Overview
Role of CMOs in the Pharmaceutical Manufacturing Value Chain
API and Intermediates and FDF Industry Ecosystem
Demand and Market Acceptance of Customers’ Products
Changing Business Model—Rise in Virtual Pharma
Virtual Pharma—Change Makers in Pharma and Biotech Outsourcing Ecosystem
Key Characteristics Influencing CMO Selection
New Business Models
Comparative Capability Analysis of Key Participants in the Pharma/ Biotech Contract Outsourcing Market
Global CMO Key Market Trends
Key Technology Trends—Inclination towards Continuous Manufacturing
Key Technology Trends—Prominence of Gamma Sterilization
Key Technology Trends—Rising Acceptance of Process Analytical Technologies (PAT)
Key Market Drivers
Key Market Restraints
Snapshot of Competitive Landscape
CMO Expansions in Products, Clinical Services, and Capacity Offerings
Differential Revenue Growth
Uncertainty Matrix—Mapping of Key CMO Industry Uncertainties
Possible Industry Overcapacity
10 Companies to Watch and Why
Key Mergers and Acquisitions
Notable Mergers and Acquisitions—CMO Industry on a Consolidation Spree
Key Merger, Acquisition, and Partnership Agreements
Key FDF CMO Segment Strategic Collaborations
Key API and Intermediates Segment Strategic Collaborations
Market Engineering Measurements
Total Pharmaceutical CMO Market Revenue Forecast
Total Pharmaceutical CMO Market Percent Revenue Forecast by Region
Total Pharmaceutical CMO Market Revenue Forecast by Region
Total Pharmaceutical CMO Market Percent Revenue Forecast by Service Type
Total Pharmaceutical CMO Market Revenue Forecast by Service Type
API and Intermediates CMO Market Overview
Value Chain of Pharmaceutical Manufacturing
Market Segmentation
API and Intermediates CMO Market Revenue Forecast
API and Intermediates CMO Market Percent Revenue Breakdown by Geographic Region
API CMO Market Percent Revenue Breakdown by Synthesis Route
API and Intermediates CMO Market Revenue Forecast by Synthesis Route
API and Intermediates CMO Market Percent Revenue Breakdown by Customer Base
API and Intermediates CMO Market Revenue Breakdown by Customer Base
Market Segmentation
FDF CMO Market Percent Revenue Breakdown by Geographic Region
FDF CMO Market Percent Revenue Forecast by Dosage Form
FDF CMO Market Percent Revenue Breakdown by Patent Exclusivity Status
FDF CMO Market Revenue Forecast
FDF CMO Market Percent Revenue Forecast by Dosage Form
FDF CMO Market Revenue Forecast by Dosage Form
Global FDF CMO Market Share Analysis
API and Intermediates CMO Market—Competitive Structure
Key CMO Breakdown by APIs and FDFs
Market Overview
Market Analysis
Market Engineering Measurements
US Pharmaceutical CMO Market Revenue Forecast
US Pharmaceutical CMO Market Revenue Forecast by Service Type
US API and Intermediates CMO Market Revenue Forecast
US FDF CMO Market Revenue Forecast
US Solid Dose Formulations Segment Revenue Forecast
US Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
US Injectable Dose Formulations Segment Revenue Forecast
Pricing Analysis
PESTLE Analysis
Patheon
Patheon—Major Partnerships and Agreements
Catalent
Catalent—Major Partnerships and Agreements
Baxter Biopharma Solutions
Market Overview
Market Analysis
Market Engineering Measurements
Western European Pharmaceutical CMO Market Revenue Forecast
Western European Pharmaceutical CMO Market Revenue Forecast by Service Type
Western European FDF CMO Market Revenue Forecast by Dosage Form
Western Europe API and Intermediates CMO Market Revenue Forecast
Western Europe FDF CMO Market Revenue Forecast
Solid Dose Formulations Segment Revenue Forecast
Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
Injectable Dose Formulations Segment Revenue Forecast
Pricing Analysis
PESTLE Analysis
Market Segmentation for Western Europe Breakdown
Germany FDF CMO Market Revenue Forecast
Germany FDF CMO Market Revenue Forecast by Dosage Form
Germany Solid Dose Formulations Segment Revenue Forecast
Germany Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
Germany Injectable Dose Formulations Segment Revenue Forecast
Aenova
Aenova—Major Partnerships and Agreements
Famar
Famar—Major Partnerships and Agreements
Fareva
Fareva—Major Partnerships and Agreements
DTP Laboratories
DPT Laboratories—Major Partnerships and Agreements
Vetter Pharma
Vetter Pharma—Major Partnerships and Agreements
Consort Medical (Aesica/Bespak)
Consort Medical—Major Partnerships and Agreements
Recipharm
Recipharm—Major Partnerships and Agreements
Market Overview
Market Engineering Measurements
APAC Pharmaceutical CMO Market Revenue Forecast
APAC Pharmaceutical CMO Market Revenue Forecast by Service Type
APAC API and Intermediates CMO Market Revenue Forecast
APAC FDF CMO Market Revenue Forecast
APAC FDF CMO Market Percent Revenue Forecast by Dosage Form
APAC FDF CMO Market Revenue Forecast by Dosage Form
Pricing Analysis
PESTLE Analysis
Market Segmentation for APAC Breakdown
Market Summary—China
China Pharmaceutical CMO Market Revenue Forecast
China Pharmaceutical CMO Market Revenue Forecast by Service Type
China API and Intermediates CMO Market Revenue Forecast
China FDF CMO Market Revenue Forecast
China FDF CMO Market Revenue Forecast by Dosage Form
China Solid Dose Formulations Segment Revenue Forecast
China Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
China Injectable Dose Formulations Segment Revenue Forecast
China Segment Discussion
Huapont Pharm Co., Ltd
Huapont Pharm Co., Ltd—Major Partnerships and Agreements
Market Summary—India
India Pharmaceutical CMO Market Revenue Forecast
India Pharmaceutical CMO Market Revenue Forecast by Service Type
India API and Intermediates CMO Market Revenue Forecast
India FDF CMO Market Revenue Forecast
India FDF CMO Market Revenue Forecast by Dosage Form
India Solid Dose Formulations Segment Revenue Forecast
India Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
India Injectable Dose Formulations Segment Revenue Forecast
Dr. Reddy’s Laboratories—Custom Pharma Services
Dr. Reddy’s Laboratories Custom Pharma Services—Major Partnerships and Agreements
Market Summary—Japan
Japan Pharmaceutical CMO Market Revenue Forecast
Japan Pharmaceutical CMO Market Revenue Forecast by Service Type
Japan API and Intermediates CMO Market Revenue Forecast
Japan FDF CMO Market Revenue Forecast
Japan FDF CMO Market Revenue Forecast by Dosage Form
Japan Solid Dose Formulations Segment Revenue Forecast
Japan Liquid and Semi-solid Dose Formulations Segment Revenue Forecast
Japan Injectable Dose Formulations Segment Revenue Forecast
Nipro Pharma Corporation
Nipro Pharma Corporation—Custom Pharma Services
Nipro Pharma Corporation—Major Partnerships and Agreements
Major Growth Opportunities
Global API Outsourcing Scenario
Growth Opportunities in API Contract Manufacturing
Emerging CMO Business Model
Risk Sharing Model—Achievable by Sharing the Following Resources
Various Differentiation Strategies to Drive Long-term Profitability of CMOs
Global Pharmaceutical CMO Market—Final Word
Legal Disclaimer
Market Engineering Methodology
List of Other Key Companies Included in This Research Service
- 1. Total Pharmaceutical CMO Market: Global Manufacturing Footprint, Global, 2015
- 2. Total Pharmaceutical CMO Market: Key Investment Trends, Global, 2012–2015
- 3. Total Pharmaceutical CMO Market: Game-changing Companies, Global, 2015
- 4. Total Pharmaceutical CMO Market: Comparative Capability Analysis of Key Participants, Global, 2015
- 5. Total Pharmaceutical CMO Market: Key Market Drivers, Global, 2016–2020
- 6. Total Pharmaceutical CMO Market: Key Market Restraints, Global, 2016–2020
- 7. Total Pharmaceutical CMO Market: Roles of CMOs in the Drug Development Process, Global, 2015
- 8. Total Pharmaceutical CMO Market: CMO Expansions, Global, 2011–2016
- 9. FDF CMO Market: Industry Capacity Analysis by Product Segment, Global, 2015
- 10. Total Pharmaceutical CMO Market: Key Mergers and Acquisitions, Global, 2012–2016
- 11. Total Pharmaceutical CMO Market: Key Merger, Acquisition, and Partnership Agreements, Global, 2014–2016
- 12. Total FDF CMO Market: Key Mergers and Acquisitions, Global, 2016
- 13. Total API and Intermediates CMO Market: Key Mergers and Acquisitions, Global, 2015
- 14. Total Pharmaceutical CMO Market: Market Engineering Measurements, Global, 2015
- 15. Total Pharmaceutical CMO Market: Revenue Forecast by Region, Global, 2012–2020
- 16. Total Pharmaceutical CMO Market: Revenue Forecast by Service Type, Global, 2012–2020
- 17. FDF CMO Market: Revenue Forecast by Dosage Form, Global, 2012–2020
- 18. FDF CMO Market: Pricing Analysis, Global, 2015
- 19. FDF CMO Market: Market Share Analysis, Global, 2015
- 20. API and Intermediates CMO Market: Competitive Structure, Global, 2015
- 21. Total Pharmaceutical CMO Market: Key CMO Breakdown by API and FDF, Global, 2015
- 22. Pharmaceutical CMO Market: Market Engineering Measurements, US, 2015
- 23. FDF CMO Market: Pricing Analysis, US, 2015
- 24. Patheon—Major Partnerships and Agreements, Global, 2012–2015
- 25. Catalent—Major Partnerships and Agreements, Global, 2015–2016
- 26. Pharmaceutical CMO Market: Market Engineering Measurements, Western Europe, 2015
- 27. FDF CMO Market: Pricing Analysis, Western Europe, 2015
- 28. Aenova—Major Partnerships and Agreements, Global, 2012–2013
- 29. Famar—Major Partnerships and Agreements, Global, 2013–2016
- 30. Fareva—Major Partnerships and Agreements, Global, 2012 and 2015
- 31. DPT Laboratories—Major Partnerships and Agreements, Global, 2013, 2014, and 2016
- 32. Vetter Pharma—Major Partnerships and Agreements, Global, 2015
- 33. Consort Medical—Major Partnerships and Agreements, Global, 2011, 2013, and 2016
- 34. Recipharm—Major Partnerships and Agreements, Global, 2014–2016
- 35. Pharmaceutical CMO Market: Market Engineering Measurements, APAC, 2015
- 36. FDF CMO Market: Revenue Forecast by Dosage Form, APAC, 2012–2020
- 37. FDF CMO Market: Pricing Analysis, APAC, 2015
- 38. Huapont Pharm—Major Partnerships and Agreements, Global, 2007 and 2013
- 39. Dr. Reddy’s Laboratories—Major Partnerships and Agreements, Global, 2012, 2014, and 2015
- 40. Nipro Pharma Corporation—Major Partnerships and Agreements, Global, 2012 and 2014
- 41. Total Pharmaceutical CMO Market: Differentiation Strategies to Improve CMO Profitability, Global, 2015
- 1. Total Pharmaceutical CMO Market: Regional Market Share, Global, 2015
- 2. Total Pharmaceutical CMO Market: Market Segmentation, Global, 2015
- 3. Total Pharmaceutical CMO Market: Market Engineering Measurements, Global, 2015
- 4. Total Pharmaceutical CMO Market: FDF CMO Trends, Global 2015
- 5. Total Pharmaceutical CMO Market: API and Intermediates CMO Trends, Global 2015
- 6. Total Pharmaceutical CMO Market: Customer Segment Revenue Contribution to CMOs, Global, 2015
- 7. Total Pharmaceutical CMO Market: Revenue Forecast, Global, 2012–2020
- 8. Total Pharmaceutical CMO Market: Percent Points Cost Comparison with the US, Global, 2015
- 9. API and Intermediates CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2012–2020
- 10. FDF CMO Market: Revenue Breakdown by Geographic Region, Global, 2012–2020
- 11. FDF CMO Market: Percentage Segment Breakdown, Global, 2015
- 12. Pharmaceutical Manufacturing Market: Role of CMOs in Value Chain, Global, 2015
- 13. Total Pharmaceutical CMO Market: Factors that Adversely Affect Demand for Customer Products, Global, 2015
- 14. Total Pharmaceutical CMO Market: Virtual Outsourcing Model, 2015
- 15. Pharmaceutical CMO Market: Key Characteristics Influencing CMO Selection, Global, 2015
- 16. Total Pharmaceutical CMO Market: Growth Drivers and Contribution, Global, 2015
- 17. Total Pharmaceutical CMO Market: Map of Key CMO Industry Uncertainties, Global, 2015
- 18. Total Pharmaceutical CMO Market: Key Mergers and Acquisitions, Global, <2001–2016
- 19. Total Pharmaceutical CMO Market: Revenue Forecast, Global, 2012–2020
- 20. Total Pharmaceutical CMO Market: Percent Points Cost Comparison with the US, Global, 2015
- 21. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Region, Global, 2012–2020
- 22. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Service Type, Global, 2012–2020
- 23. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Service Type, Global, 2012–2020
- 24. API and Intermediates CMO Market: Market Segmentation, Global, 2015
- 25. API and Intermediates CMO Market: Revenue Forecast, Global, 2012–2020
- 26. API and Intermediates CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2015–2020
- 27. API and Intermediates CMO Market: Percent Revenue Breakdown by Synthesis Route, Global, 2015–2020
- 28. API and Intermediates CMO Market: Revenue Forecast by Synthesis Route, Global, 2012–2020
- 29. API and Intermediates CMO Market: Percent Revenue Breakdown by Customer Base, Global, 2015–2020
- 30. API and Intermediates CMO Market: Revenue Forecast by Customer Base, Global, 2012–2020
- 31. FDF CMO Market: Market Segmentation, Global, 2015
- 32. FDF CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2015–2020
- 33. FDF CMO Market: Percent Revenue Breakdown by Segments, Global, 2015
- 34. FDF CMO Market: Percent Revenue Forecast Breakdown by Segments, Global, 2020
- 35. FDF CMO Market: Percent Revenue Breakdown by Patent Exclusivity Status, Global, 2015
- 36. FDF CMO Market: Revenue Forecast, Global, 2012–2020
- 37. FDF CMO Market: Percent Revenue Forecast by Dosage Form, Global, 2012–2020
- 38. FDF CMO Market: Market Share by Company, Global, 2015
- 39. Pharmaceutical CMO Market: Revenue Forecast, US, 2012–2020
- 40. Pharmaceutical CMO Market: Revenue Forecast by Service Type, US, 2012–2020
- 41. API and Intermediates CMO Market: Revenue Forecast, US, 2012–2020
- 42. FDF CMO Market: Revenue Forecast, US, 2012–2020
- 43. Solid Dose Formulations Segment: Revenue Forecast, US, 2012–2020
- 44. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, US, 2012–2020
- 45. Injectable Dose Formulations Segment: Revenue Forecast, US, 2012–2020
- 46. Pharmaceutical CMO Market: Revenue Forecast, Western Europe, 2012–2020
- 47. Pharmaceutical CMO Market: Revenue Forecast by Service Type, Western Europe, 2012–2020
- 48. FDF CMO Market: Revenue Forecast Finished Dosage Form, Western Europe, 2012–2020
- 49. API and Intermediates CMO Market: Revenue Forecast, Western Europe, 2012–2020
- 50. FDF CMO Market: Revenue Forecast, Western Europe, 2012–2020
- 51. Solid Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020
- 52. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020
- 53. Injectable Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020
- 54. FDF CMO Market: Revenue Forecast, Germany, 2012–2020
- 55. FDF CMO Market: Revenue Forecast by Dosage Form, Germany, 2012–2020
- 56. Solid Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020
- 57. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020
- 58. Injectable Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020
- 59. FDF CMO Market: Revenue Forecast, UK, 2012–2020
- 60. FDF CMO Market: Revenue Forecast by Dosage Form, UK, 2012–2020
- 61. Solid Dose Formulations Segment: Revenue Forecast, UK, 2012–2020
- 62. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, UK, 2012–2020
- 63. Injectable Dose Formulations Segment: Revenue Forecast, UK, 2012–2020
- 64. FDF CMO Market: Revenue Forecast, France, 2012–2020
- 65. FDF CMO Market: Revenue Forecast by Dosage Form, France, 2012–2020
- 66. Solid Dose Formulations Segment: Revenue Forecast, France, 2012–2020
- 67. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, France, 2012–2020
- 68. Injectable Dose Formulations Segment: Revenue Forecast, France, 2012–2020
- 69. FDF CMO Market: Revenue Forecast, Italy, 2012–2020
- 70. FDF CMO Market: Revenue Forecast by Dosage Form, Italy, 2012–2020
- 71. Solid Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020
- 72. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020
- 73. Injectable Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020
- 74. FDF CMO Market: Revenue Forecast, Spain, 2012–2020
- 75. FDF CMO Market: Revenue Forecast by Dosage Form, Spain, 2012–2020
- 76. Solid Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020
- 77. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020
- 78. Injectable Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020
- 79. FDF CMO Market: Revenue Forecast, Scandinavia, 2012–2020
- 80. FDF CMO Market: Revenue Forecast by Dosage Form, Scandinavia, 2012–2020
- 81. Solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020
- 82. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020
- 83. Injectable Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020
- 84. FDF CMO Market: Revenue Forecast, Benelux, 2012–2020
- 85. FDF CMO Market: Revenue Forecast by Dosage Form, Benelux, 2012–2020
- 86. Solid Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020
- 87. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020
- 88. Injectable Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020
- 89. Pharmaceutical CMO Market: Revenue Forecast, APAC, 2012–2020
- 90. Pharmaceutical CMO Market: Revenue Forecast by Service Type, APAC, 2012–2020
- 91. API and Intermediates CMO Market: Revenue Forecast, APAC, 2012–2020
- 92. FDF CMO Market: Revenue Forecast, APAC, 2012–2020
- 93. FDF CMO Market: Percent Revenue Forecast by Dosage Form, APAC, 2012–2020
- 94. Pharmaceutical CMO Market: PESTLE Analysis, APAC, 2015
- 95. Pharmaceutical CMO Market: Revenue Forecast, China, 2012–2020
- 96. Pharmaceutical CMO Market: Revenue Forecast by Service Type, China, 2012–2020
- 97. API and Intermediates CMO Market: Revenue Forecast, China, 2012–2020
- 98. FDF CMO Market: Revenue Forecast, China, 2012–2020
- 99. FDF CMO Market: Revenue Forecast by Dosage Form, China, 2012–2020
- 100. Solid Dose Formulations Segment: Revenue Forecast, China, 2012–2020
- 101. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, China, 2012–2020
- 102. Injectable Dose Formulations Segment: Revenue Forecast, China, 2012–2020
- 103. Pharmaceutical CMO Market: Revenue Forecast, India, 2012–2020
- 104. Pharmaceutical CMO Market: Revenue Forecast by Service Type, India, 2012–2020
- 105. API and Intermediates CMO Market: Revenue Forecast, India, 2012–2020
- 106. FDF CMO Market: Revenue Forecast, India, 2012–2020
- 107. FDF CMO Market: Revenue Forecast by Dosage Form, India, 2012–2020
- 108. Solid Dose Formulations Segment: Revenue Forecast, India, 2012–2020
- 109. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, India, 2012–2020
- 110. Injectable Dose Formulations Segment: Revenue Forecast, India, 2012–2020
- 111. Pharmaceutical CMO Market: Revenue Forecast, Japan, 2012–2020
- 112. Pharmaceutical CMO Market: Revenue Forecast by Service Type, Japan, 2012–2020
- 113. API and Intermediates CMO Market: Revenue Forecast, Japan, 2012–2020
- 114. FDF CMO Market: Revenue Forecast, Japan, 2012–2020
- 115. FDF CMO Market: Revenue Forecast by Dosage Form, Japan, 2012–2020
- 116. Solid Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020
- 117. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020
- 118. Injectable Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020
- 119. API Contract Manufacturing Market: Revenue by Region, 2012–2016
- 120. Pharmaceutical CMO Market: Emerging Business Models, 2016
Popular Topics
No Index | No |
---|---|
Podcast | No |
Table of Contents | | Executive Summary~ || Key Findings—Pharmaceutical CMO Market~ || Scope and Geographic Segmentation~ || Market Segmentation~ || Methodology~ || Market Engineering Measurements~ ||| Market Overview~ ||| Competitor Overview~ ||| Total Addressable Market~ ||| Industry Advancement~ || Global Manufacturing Footprint—Key CMO Companies~ || Transformation of Industry Ecosystem~ || Trends for the FDF CMO Market~ || Trends for the API and Intermediates CMO Market~ || Key Technology Trends—Preference for Disposable Technologies~ || Key Technology Trends—Rising Demand of Lyophilization~ || Key Investment Trends~ || Game-changing Companies~ || Customer Segment Revenue Contribution Analysis~ || 8 Big Market Themes for Contract Manufacturing~ | Global CMO Market Landscape~ || Total Pharmaceutical CMO Market Revenue Forecast~ || API and Intermediates CMO Market Overview~ || FDF CMO Market Overview~ || Role of CMOs in the Pharmaceutical Manufacturing Value Chain~ || API and Intermediates and FDF Industry Ecosystem~ || Demand and Market Acceptance of Customers’ Products~ || Changing Business Model—Rise in Virtual Pharma~ || Virtual Pharma—Change Makers in Pharma and Biotech Outsourcing Ecosystem~ || Key Characteristics Influencing CMO Selection~ || New Business Models~ || Comparative Capability Analysis of Key Participants in the Pharma/ Biotech Contract Outsourcing Market~ || Global CMO Key Market Trends~ || Key Technology Trends—Inclination towards Continuous Manufacturing~ || Key Technology Trends—Prominence of Gamma Sterilization~ || Key Technology Trends—Rising Acceptance of Process Analytical Technologies (PAT)~ || Key Market Drivers~ ||| Core competencies~ ||| Consolidation/ acquisitions~ ||| Increasing outsourcing volume by big pharma~ ||| Blockbuster drugs coming out of patent~ ||| Expanding services of CMOs~ ||| Increased adherence to a risk-sharing model will support virtual pharmaceutical~ ||| CDMO model~ || Key Market Restraints~ ||| Stringent regulatory requirements~ ||| Cost Pressure on pharma companies~ ||| Lack of venture capital (VC) funding for early-stage companies~ ||| Dependence on key starting materials and lack of substitutes~ ||| Lower unit volumes and new technologies~ | Competitive Playbook~ || Snapshot of Competitive Landscape~ || CMO Expansions in Products, Clinical Services, and Capacity Offerings~ || Differential Revenue Growth~ || Uncertainty Matrix—Mapping of Key CMO Industry Uncertainties~ || Possible Industry Overcapacity~ || 10 Companies to Watch and Why~ | Key Merger, Acquisition, and Partnership Agreements of the Contract Manufacturing Markets~ || Key Mergers and Acquisitions~ || Notable Mergers and Acquisitions—CMO Industry on a Consolidation Spree~ || Key Merger, Acquisition, and Partnership Agreements~ || Key FDF CMO Segment Strategic Collaborations~ || Key API and Intermediates Segment Strategic Collaborations~ | Forecast and Trends~ || Market Engineering Measurements~ || Total Pharmaceutical CMO Market Revenue Forecast~ || Total Pharmaceutical CMO Market Percent Revenue Forecast by Region~ || Total Pharmaceutical CMO Market Revenue Forecast by Region~ | Total Pharmaceutical CMO Market Forecast by Service Type~ || Total Pharmaceutical CMO Market Percent Revenue Forecast by Service Type~ || Total Pharmaceutical CMO Market Revenue Forecast by Service Type~ | Global API and Intermediates CMO Market Breakdown~ || API and Intermediates CMO Market Overview~ || Value Chain of Pharmaceutical Manufacturing~ || Market Segmentation~ || API and Intermediates CMO Market Revenue Forecast~ || API and Intermediates CMO Market Percent Revenue Breakdown by Geographic Region~ || API CMO Market Percent Revenue Breakdown by Synthesis Route~ || API and Intermediates CMO Market Revenue Forecast by Synthesis Route~ || API and Intermediates CMO Market Percent Revenue Breakdown by Customer Base~ || API and Intermediates CMO Market Revenue Breakdown by Customer Base~ | Global FDF CMO Market Breakdown~ || Market Segmentation~ || FDF CMO Market Percent Revenue Breakdown by Geographic Region~ || FDF CMO Market Percent Revenue Forecast by Dosage Form~ || FDF CMO Market Percent Revenue Breakdown by Patent Exclusivity Status~ || FDF CMO Market Revenue Forecast~ || FDF CMO Market Percent Revenue Forecast by Dosage Form~ || FDF CMO Market Revenue Forecast by Dosage Form~ | Market Share and Competitive Analysis~ || Global FDF CMO Market Share Analysis~ || API and Intermediates CMO Market—Competitive Structure~ || Key CMO Breakdown by APIs and FDFs~ | United States Breakdown~ || Market Overview~ || Market Analysis~ || Market Engineering Measurements~ || US Pharmaceutical CMO Market Revenue Forecast~ || US Pharmaceutical CMO Market Revenue Forecast by Service Type~ | US API and Intermediates CMO Market~ || US API and Intermediates CMO Market Revenue Forecast~ | US FDF CMO Market Breakdown~ || US FDF CMO Market Revenue Forecast~ || US Solid Dose Formulations Segment Revenue Forecast~ || US Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || US Injectable Dose Formulations Segment Revenue Forecast~ || Pricing Analysis~ || PESTLE Analysis~ | US—Key Companies to Watch~ || Patheon~ || Patheon—Major Partnerships and Agreements~ || Catalent~ || Catalent—Major Partnerships and Agreements~ || Baxter Biopharma Solutions~ | Western Europe Breakdown~ || Market Overview~ || Market Analysis~ || Market Engineering Measurements~ || Western European Pharmaceutical CMO Market Revenue Forecast~ || Western European Pharmaceutical CMO Market Revenue Forecast by Service Type~ || Western European FDF CMO Market Revenue Forecast by Dosage Form~ | Western Europe API and Intermediates CMO Market Breakdown~ || Western Europe API and Intermediates CMO Market Revenue Forecast~ | Western Europe FDF CMO Market Breakdown~ || Western Europe FDF CMO Market Revenue Forecast~ || Solid Dose Formulations Segment Revenue Forecast~ || Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || Injectable Dose Formulations Segment Revenue Forecast~ || Pricing Analysis~ || PESTLE Analysis~ | Breakdown by Key Western Europe Countries~ || Market Segmentation for Western Europe Breakdown~ | Germany Breakdown~ || Germany FDF CMO Market Revenue Forecast~ || Germany FDF CMO Market Revenue Forecast by Dosage Form~ || Germany Solid Dose Formulations Segment Revenue Forecast~ || Germany Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || Germany Injectable Dose Formulations Segment Revenue Forecast~ | UK Breakdown~ | France Breakdown~ | Italy Breakdown~ | Spain Breakdown~ | Scandinavia Breakdown~ | Benelux Breakdown~ | Western Europe—Key Companies to Watch~ || Aenova~ || Aenova—Major Partnerships and Agreements~ || Famar~ || Famar—Major Partnerships and Agreements~ || Fareva~ || Fareva—Major Partnerships and Agreements~ || DTP Laboratories~ || DPT Laboratories—Major Partnerships and Agreements~ || Vetter Pharma~ || Vetter Pharma—Major Partnerships and Agreements~ || Consort Medical (Aesica/Bespak)~ || Consort Medical—Major Partnerships and Agreements~ || Recipharm~ || Recipharm—Major Partnerships and Agreements~ | APAC Breakdown~ || Market Overview~ || Market Engineering Measurements~ || APAC Pharmaceutical CMO Market Revenue Forecast~ || APAC Pharmaceutical CMO Market Revenue Forecast by Service Type~ | APAC API and Intermediates CMO Market Breakdown~ || APAC API and Intermediates CMO Market Revenue Forecast~ | APAC FDF CMO Market Breakdown~ || APAC FDF CMO Market Revenue Forecast~ || APAC FDF CMO Market Percent Revenue Forecast by Dosage Form~ || APAC FDF CMO Market Revenue Forecast by Dosage Form~ || Pricing Analysis~ || PESTLE Analysis~ | Breakdown by Key APAC Countries~ || Market Segmentation for APAC Breakdown~ | China Breakdown~ || Market Summary—China~ || China Pharmaceutical CMO Market Revenue Forecast~ || China Pharmaceutical CMO Market Revenue Forecast by Service Type~ || China API and Intermediates CMO Market Revenue Forecast~ || China FDF CMO Market Revenue Forecast~ || China FDF CMO Market Revenue Forecast by Dosage Form~ || China Solid Dose Formulations Segment Revenue Forecast~ || China Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || China Injectable Dose Formulations Segment Revenue Forecast~ || China Segment Discussion~ || Huapont Pharm Co., Ltd~ || Huapont Pharm Co., Ltd—Major Partnerships and Agreements~ | India Breakdown~ || Market Summary—India~ || India Pharmaceutical CMO Market Revenue Forecast~ || India Pharmaceutical CMO Market Revenue Forecast by Service Type~ || India API and Intermediates CMO Market Revenue Forecast~ || India FDF CMO Market Revenue Forecast~ || India FDF CMO Market Revenue Forecast by Dosage Form~ || India Solid Dose Formulations Segment Revenue Forecast~ || India Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || India Injectable Dose Formulations Segment Revenue Forecast~ || Dr. Reddy’s Laboratories—Custom Pharma Services~ || Dr. Reddy’s Laboratories Custom Pharma Services—Major Partnerships and Agreements~ | Japan Breakdown~ || Market Summary—Japan~ || Japan Pharmaceutical CMO Market Revenue Forecast~ || Japan Pharmaceutical CMO Market Revenue Forecast by Service Type~ || Japan API and Intermediates CMO Market Revenue Forecast~ || Japan FDF CMO Market Revenue Forecast~ || Japan FDF CMO Market Revenue Forecast by Dosage Form~ || Japan Solid Dose Formulations Segment Revenue Forecast~ || Japan Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || Japan Injectable Dose Formulations Segment Revenue Forecast~ || Nipro Pharma Corporation~ || Nipro Pharma Corporation—Custom Pharma Services~ || Nipro Pharma Corporation—Major Partnerships and Agreements~ | The Last Word—Strategic Considerations for Staying on Growth Trajectory~ || Major Growth Opportunities~ || Global API Outsourcing Scenario~ || Growth Opportunities in API Contract Manufacturing~ || Emerging CMO Business Model~ || Risk Sharing Model—Achievable by Sharing the Following Resources~ || Various Differentiation Strategies to Drive Long-term Profitability of CMOs~ || Global Pharmaceutical CMO Market—Final Word~ || Legal Disclaimer~ | Appendix~ || Market Engineering Methodology~ || List of Other Key Companies Included in This Research Service~ |
List of Charts and Figures | 1. Total Pharmaceutical CMO Market: Global Manufacturing Footprint, Global, 2015~ 2. Total Pharmaceutical CMO Market: Key Investment Trends, Global, 2012–2015~ 3. Total Pharmaceutical CMO Market: Game-changing Companies, Global, 2015~ 4. Total Pharmaceutical CMO Market: Comparative Capability Analysis of Key Participants, Global, 2015~ 5. Total Pharmaceutical CMO Market: Key Market Drivers, Global, 2016–2020~ 6. Total Pharmaceutical CMO Market: Key Market Restraints, Global, 2016–2020~ 7. Total Pharmaceutical CMO Market: Roles of CMOs in the Drug Development Process, Global, 2015~ 8. Total Pharmaceutical CMO Market: CMO Expansions, Global, 2011–2016~ 9. FDF CMO Market: Industry Capacity Analysis by Product Segment, Global, 2015~ 10. Total Pharmaceutical CMO Market: Key Mergers and Acquisitions, Global, 2012–2016~ 11. Total Pharmaceutical CMO Market: Key Merger, Acquisition, and Partnership Agreements, Global, 2014–2016~ 12. Total FDF CMO Market: Key Mergers and Acquisitions, Global, 2016~ 13. Total API and Intermediates CMO Market: Key Mergers and Acquisitions, Global, 2015~ 14. Total Pharmaceutical CMO Market: Market Engineering Measurements, Global, 2015~ 15. Total Pharmaceutical CMO Market: Revenue Forecast by Region, Global, 2012–2020~ 16. Total Pharmaceutical CMO Market: Revenue Forecast by Service Type, Global, 2012–2020~ 17. FDF CMO Market: Revenue Forecast by Dosage Form, Global, 2012–2020~ 18. FDF CMO Market: Pricing Analysis, Global, 2015~ 19. FDF CMO Market: Market Share Analysis, Global, 2015~ 20. API and Intermediates CMO Market: Competitive Structure, Global, 2015~ 21. Total Pharmaceutical CMO Market: Key CMO Breakdown by API and FDF, Global, 2015~ 22. Pharmaceutical CMO Market: Market Engineering Measurements, US, 2015~ 23. FDF CMO Market: Pricing Analysis, US, 2015~ 24. Patheon—Major Partnerships and Agreements, Global, 2012–2015~ 25. Catalent—Major Partnerships and Agreements, Global, 2015–2016~ 26. Pharmaceutical CMO Market: Market Engineering Measurements, Western Europe, 2015~ 27. FDF CMO Market: Pricing Analysis, Western Europe, 2015~ 28. Aenova—Major Partnerships and Agreements, Global, 2012–2013~ 29. Famar—Major Partnerships and Agreements, Global, 2013–2016~ 30. Fareva—Major Partnerships and Agreements, Global, 2012 and 2015~ 31. DPT Laboratories—Major Partnerships and Agreements, Global, 2013, 2014, and 2016~ 32. Vetter Pharma—Major Partnerships and Agreements, Global, 2015~ 33. Consort Medical—Major Partnerships and Agreements, Global, 2011, 2013, and 2016~ 34. Recipharm—Major Partnerships and Agreements, Global, 2014–2016~ 35. Pharmaceutical CMO Market: Market Engineering Measurements, APAC, 2015~ 36. FDF CMO Market: Revenue Forecast by Dosage Form, APAC, 2012–2020~ 37. FDF CMO Market: Pricing Analysis, APAC, 2015~ 38. Huapont Pharm—Major Partnerships and Agreements, Global, 2007 and 2013~ 39. Dr. Reddy’s Laboratories—Major Partnerships and Agreements, Global, 2012, 2014, and 2015~ 40. Nipro Pharma Corporation—Major Partnerships and Agreements, Global, 2012 and 2014~ 41. Total Pharmaceutical CMO Market: Differentiation Strategies to Improve CMO Profitability, Global, 2015~| 1. Total Pharmaceutical CMO Market: Regional Market Share, Global, 2015~ 2. Total Pharmaceutical CMO Market: Market Segmentation, Global, 2015~ 3. Total Pharmaceutical CMO Market: Market Engineering Measurements, Global, 2015~ 4. Total Pharmaceutical CMO Market: FDF CMO Trends, Global 2015~ 5. Total Pharmaceutical CMO Market: API and Intermediates CMO Trends, Global 2015~ 6. Total Pharmaceutical CMO Market: Customer Segment Revenue Contribution to CMOs, Global, 2015~ 7. Total Pharmaceutical CMO Market: Revenue Forecast, Global, 2012–2020~ 8. Total Pharmaceutical CMO Market: Percent Points Cost Comparison with the US, Global, 2015~ 9. API and Intermediates CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2012–2020~ 10. FDF CMO Market: Revenue Breakdown by Geographic Region, Global, 2012–2020~ 11. FDF CMO Market: Percentage Segment Breakdown, Global, 2015~ 12. Pharmaceutical Manufacturing Market: Role of CMOs in Value Chain, Global, 2015~ 13. Total Pharmaceutical CMO Market: Factors that Adversely Affect Demand for Customer Products, Global, 2015~ 14. Total Pharmaceutical CMO Market: Virtual Outsourcing Model, 2015~ 15. Pharmaceutical CMO Market: Key Characteristics Influencing CMO Selection, Global, 2015~ 16. Total Pharmaceutical CMO Market: Growth Drivers and Contribution, Global, 2015~ 17. Total Pharmaceutical CMO Market: Map of Key CMO Industry Uncertainties, Global, 2015~ 18. Total Pharmaceutical CMO Market: Key Mergers and Acquisitions, Global, <2001–2016~ 19. Total Pharmaceutical CMO Market: Revenue Forecast, Global, 2012–2020~ 20. Total Pharmaceutical CMO Market: Percent Points Cost Comparison with the US, Global, 2015~ 21. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Region, Global, 2012–2020~ 22. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Service Type, Global, 2012–2020~ 23. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Service Type, Global, 2012–2020~ 24. API and Intermediates CMO Market: Market Segmentation, Global, 2015~ 25. API and Intermediates CMO Market: Revenue Forecast, Global, 2012–2020~ 26. API and Intermediates CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2015–2020~ 27. API and Intermediates CMO Market: Percent Revenue Breakdown by Synthesis Route, Global, 2015–2020~ 28. API and Intermediates CMO Market: Revenue Forecast by Synthesis Route, Global, 2012–2020~ 29. API and Intermediates CMO Market: Percent Revenue Breakdown by Customer Base, Global, 2015–2020~ 30. API and Intermediates CMO Market: Revenue Forecast by Customer Base, Global, 2012–2020~ 31. FDF CMO Market: Market Segmentation, Global, 2015~ 32. FDF CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2015–2020~ 33. FDF CMO Market: Percent Revenue Breakdown by Segments, Global, 2015~ 34. FDF CMO Market: Percent Revenue Forecast Breakdown by Segments, Global, 2020~ 35. FDF CMO Market: Percent Revenue Breakdown by Patent Exclusivity Status, Global, 2015~ 36. FDF CMO Market: Revenue Forecast, Global, 2012–2020~ 37. FDF CMO Market: Percent Revenue Forecast by Dosage Form, Global, 2012–2020~ 38. FDF CMO Market: Market Share by Company, Global, 2015~ 39. Pharmaceutical CMO Market: Revenue Forecast, US, 2012–2020~ 40. Pharmaceutical CMO Market: Revenue Forecast by Service Type, US, 2012–2020~ 41. API and Intermediates CMO Market: Revenue Forecast, US, 2012–2020~ 42. FDF CMO Market: Revenue Forecast, US, 2012–2020~ 43. Solid Dose Formulations Segment: Revenue Forecast, US, 2012–2020~ 44. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, US, 2012–2020~ 45. Injectable Dose Formulations Segment: Revenue Forecast, US, 2012–2020~ 46. Pharmaceutical CMO Market: Revenue Forecast, Western Europe, 2012–2020~ 47. Pharmaceutical CMO Market: Revenue Forecast by Service Type, Western Europe, 2012–2020~ 48. FDF CMO Market: Revenue Forecast Finished Dosage Form, Western Europe, 2012–2020~ 49. API and Intermediates CMO Market: Revenue Forecast, Western Europe, 2012–2020~ 50. FDF CMO Market: Revenue Forecast, Western Europe, 2012–2020~ 51. Solid Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020~ 52. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020~ 53. Injectable Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020~ 54. FDF CMO Market: Revenue Forecast, Germany, 2012–2020~ 55. FDF CMO Market: Revenue Forecast by Dosage Form, Germany, 2012–2020~ 56. Solid Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020~ 57. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020~ 58. Injectable Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020~ 59. FDF CMO Market: Revenue Forecast, UK, 2012–2020~ 60. FDF CMO Market: Revenue Forecast by Dosage Form, UK, 2012–2020~ 61. Solid Dose Formulations Segment: Revenue Forecast, UK, 2012–2020~ 62. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, UK, 2012–2020~ 63. Injectable Dose Formulations Segment: Revenue Forecast, UK, 2012–2020~ 64. FDF CMO Market: Revenue Forecast, France, 2012–2020~ 65. FDF CMO Market: Revenue Forecast by Dosage Form, France, 2012–2020~ 66. Solid Dose Formulations Segment: Revenue Forecast, France, 2012–2020~ 67. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, France, 2012–2020~ 68. Injectable Dose Formulations Segment: Revenue Forecast, France, 2012–2020~ 69. FDF CMO Market: Revenue Forecast, Italy, 2012–2020~ 70. FDF CMO Market: Revenue Forecast by Dosage Form, Italy, 2012–2020~ 71. Solid Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020~ 72. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020~ 73. Injectable Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020~ 74. FDF CMO Market: Revenue Forecast, Spain, 2012–2020~ 75. FDF CMO Market: Revenue Forecast by Dosage Form, Spain, 2012–2020~ 76. Solid Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020~ 77. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020~ 78. Injectable Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020~ 79. FDF CMO Market: Revenue Forecast, Scandinavia, 2012–2020~ 80. FDF CMO Market: Revenue Forecast by Dosage Form, Scandinavia, 2012–2020~ 81. Solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020~ 82. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020~ 83. Injectable Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020~ 84. FDF CMO Market: Revenue Forecast, Benelux, 2012–2020~ 85. FDF CMO Market: Revenue Forecast by Dosage Form, Benelux, 2012–2020~ 86. Solid Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020~ 87. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020~ 88. Injectable Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020~ 89. Pharmaceutical CMO Market: Revenue Forecast, APAC, 2012–2020~ 90. Pharmaceutical CMO Market: Revenue Forecast by Service Type, APAC, 2012–2020~ 91. API and Intermediates CMO Market: Revenue Forecast, APAC, 2012–2020~ 92. FDF CMO Market: Revenue Forecast, APAC, 2012–2020~ 93. FDF CMO Market: Percent Revenue Forecast by Dosage Form, APAC, 2012–2020~ 94. Pharmaceutical CMO Market: PESTLE Analysis, APAC, 2015~ 95. Pharmaceutical CMO Market: Revenue Forecast, China, 2012–2020~ 96. Pharmaceutical CMO Market: Revenue Forecast by Service Type, China, 2012–2020~ 97. API and Intermediates CMO Market: Revenue Forecast, China, 2012–2020~ 98. FDF CMO Market: Revenue Forecast, China, 2012–2020~ 99. FDF CMO Market: Revenue Forecast by Dosage Form, China, 2012–2020~ 100. Solid Dose Formulations Segment: Revenue Forecast, China, 2012–2020~ 101. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, China, 2012–2020~ 102. Injectable Dose Formulations Segment: Revenue Forecast, China, 2012–2020~ 103. Pharmaceutical CMO Market: Revenue Forecast, India, 2012–2020~ 104. Pharmaceutical CMO Market: Revenue Forecast by Service Type, India, 2012–2020~ 105. API and Intermediates CMO Market: Revenue Forecast, India, 2012–2020~ 106. FDF CMO Market: Revenue Forecast, India, 2012–2020~ 107. FDF CMO Market: Revenue Forecast by Dosage Form, India, 2012–2020~ 108. Solid Dose Formulations Segment: Revenue Forecast, India, 2012–2020~ 109. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, India, 2012–2020~ 110. Injectable Dose Formulations Segment: Revenue Forecast, India, 2012–2020~ 111. Pharmaceutical CMO Market: Revenue Forecast, Japan, 2012–2020~ 112. Pharmaceutical CMO Market: Revenue Forecast by Service Type, Japan, 2012–2020~ 113. API and Intermediates CMO Market: Revenue Forecast, Japan, 2012–2020~ 114. FDF CMO Market: Revenue Forecast, Japan, 2012–2020~ 115. FDF CMO Market: Revenue Forecast by Dosage Form, Japan, 2012–2020~ 116. Solid Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020~ 117. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020~ 118. Injectable Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020~ 119. API Contract Manufacturing Market: Revenue by Region, 2012–2016~ 120. Pharmaceutical CMO Market: Emerging Business Models, 2016~ |
Lightbox Content | World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019 |
Author | Unmesh Lal |
Industries | Healthcare |
WIP Number | P8D4-01-00-00-00 |
Keyword 1 | pharmaceutical contract manufacturing market |
Keyword 2 | contract manufacturing growth |
Keyword 3 | Contract Manufacturing Organization |
Is Prebook | No |